Heiko Von Der Leyen

Title: Heiko Von Der Leyen: Innovator in Gene Therapy

Introduction

Heiko Von Der Leyen is a notable inventor based in Sehnde, Germany. He has made significant contributions to the field of gene therapy, particularly through his innovative approaches to intracellular delivery of nucleic acids. His work has the potential to revolutionize treatments for various medical conditions.

Latest Patents

Heiko Von Der Leyen holds a patent for the "Intracellular delivery of nucleic acids using pressure." This patent describes a method where naked nucleic acids, such as DNA and RNA, along with drugs and other molecules, can enter cells in living intact tissue upon the application of pressure. The method achieves transfection efficiencies greater than 90% for naked DNA and RNA. The invention involves a sealed enclosure that contains the cells and their extracellular environment, which is pressurized to an incubation pressure on the order of atmospheres. This innovative approach has applications in gene therapy, including ex-vivo treatment of grafts prior to transplantation and in-vivo treatment of tissue.

Career Highlights

Heiko Von Der Leyen is affiliated with Leland Stanford Junior University, where he continues to advance his research in gene therapy. His work has garnered attention for its potential to improve therapeutic outcomes in various medical fields.

Collaborations

Heiko has collaborated with notable colleagues such as Frank P Diet and Victor J Dzau, contributing to the advancement of research in gene therapy and related fields.

Conclusion

Heiko Von Der Leyen's innovative work in the field of gene therapy exemplifies the potential of pressure-based methods for intracellular delivery of nucleic acids. His contributions are paving the way for new therapeutic strategies that could significantly impact patient care.